COPD News

Despite clinical guidelines advising against the practice, nearly half of elderly patients presenting to a PCP for a nonbacterial acute upper respiratory infection were prescribed antibiotics, according to research published in Annals of Internal Medicine.

Extrafine fixed triple therapy had clinically beneficial effects on quality of life, hyperinflation, forced expiratory volume1 and exacerbations in patients with COPD when compared with long-acting muscarinic antagonist monotherapy, according to research recently published in The Lancet.

High intake of fruits and vegetables significantly lowered the incidence of COPD in former and current smokers, according to findings published in Thorax.

In France, researchers associated rising incidence of severe COPD exacerbations with increasing intensive care unit admissions, according to recent study results.

New research of ever-smokers shows spirometrically-defined COPD states are not uniformly progressive and can improve with airflow severity staging or resolve spirometric abnormalities over time, according to a study published in Respiratory Research.

NEW YORK — Revolutionary developments toward respiratory syncytial virus prevention and vaccination plans, such as inhibiting RNA, targeting the RSV-F protein and blocking polymerase, are currently undergoing clinical testing, according to a presentation at the 2016 Infectious Diseases in Children Symposium.

In people with chronic obstructive pulmonary disease, motor vehicle traffic density related to significant reductions in lung function, according to recent study findings.

New research links high levels of serological biomarkers of collagen remodeling with increased mortality in patients with chronic obstructive pulmonary disease, revealing assessment of tissue turnover in the parenchyma and small airways can help the prognosis of COPD, according to a recent study published in Respiratory Research.

Tiotropium Respimat and tiotropium HandiHaler are similarly safe and effective in managing chronic obstructive pulmonary disease; therefore, physicians should consider factors other than clinical outcomes when prescribing an inhaler, according to recent findings published in BMC Pulmonary Medicine.

Cancers associated with tobacco use make up 40% of all United States cancer diagnoses, and tobacco use remains the leading preventable cause of cancer and cancer deaths in the United States, according to a recent CDC Vital Signs report.